Should You Buy Shares of This Top CBD Company After Earnings?

Charlotte’s Web Holdings Inc (TSX:CWEB) holds the largest share of the U.S. CBD market. Here is why the firm’s stock is worth considering.

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

With the passage of the Farm Bill in the U.S. at the end of last year, companies that focus on the hemp-based CBD market are experiencing strong sales and revenue growth. The future of this industry is bright, and Charlotte’s Web Holdings (TSX:CWEB) is arguably better positioned than any of its peers to profit from it. The Colorado-based firm recently released its Q2 2019 financial results. Let’s see how the pot company performed during the second quarter. 

Top line keeps growing 

Charlotte’s Web was able to ramp its production capacity to new levels this year thanks to less restrictive laws. The firm’s hemp acreage increased by 187% compared to 2018. This helped the company deliver strong revenue growth. CWEB posted a 45% year-over-year organic top-line growth. The company’s gross margin of 75% — resulting in a gross profit of $18.8 million — is also commendable. Finally, unlike many of its peers in the industry, CWEB has been consistently profitable for a while. During the second quarter, the company posted net earnings of $2.2 million, though that represents a 40% decrease year over year. 

Investing for the future

Charlotte’s Web spent a lot of funds to increase its production capacity. This move came as a growing number of brick-and-mortar stores are carrying its products. CWEB’s products can be found in over 8,000 retail stores in the U.S., including such major retailers as CVS Health. It isn’t surprising that the company would spend the money necessary to keep up with this increasing retail presence.

Further, CWEB expects the demand for CBD-based products to continue on an upward trajectory. After all, the entire cannabis industry is growing, and the CBD market is especially appealing to both recreational and medical users. CWEB is also diversifying its product offerings. During the second quarter, the company introduced CBD-based gummies and a line of products for pets — the latter of which is already making the rounds.

The company secured two distribution partners for its products for pets. One of them is Pacific Pet, a California-based pet food store with a significant presence in the west coast. The other is Pet Food Experts, a store with a significant retail presence in about a handful of states.

Deanie Elner, Charlotte’s Web newly appointed CEO, said the following: “We are experiencing increased momentum with large retailers as consumer awareness and interest in CBD grows. We believe we’ll continue to see additional large retailers coming on board and expect an increase in the number of states and locations with our existing retail partners throughout the year. Kroger is the most recent example as they added four new states to their distribution in July, including Texas, which is the latest state to approve hemp CBD products.”

The bottom line

If the demand for CBD product continues to grow, as CWEB is anticipating, the firm will likely remain one of the leaders in the market. With an increasing presence across U.S. states and a growing portfolio of products, Charlotte’s Web might be one of the top companies to invest in to profit from the soaring CBD market. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool owns shares of Charlotte's Web Holdings.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »